相关实验视频
Updated: Jan 8, 2026

09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
3.3K
血栓性血栓细胞损伤性紫外线
Manal Yebari1, Aya Elkhlifi1, Douaa Elhmaidi1
1Department of Cardiology, CHU Ibn Sina, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University, Avenue Ibn Rochd, Agdal, Rabat 10100, Morocco.
European heart journal. Case reports
|December 12, 2025
概括
血栓性血栓细胞衰竭性紫外线 (TTP) 是常见的抗血小板药物克洛皮多格雷尔的一种罕见但严重的不良反应. 快速识别和取消克洛皮多格雷尔对于管理TTP和改善患者的治疗结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 血栓性血栓细胞衰竭紫外线 (TTP) 是一种罕见的,危及生命的血栓性微血管病变.
- 克洛皮多格雷尔经常用于ST升高心肌梗塞 (STEMI) 的皮肤穿透后冠状动脉干预 (PCI).
- TTP是克洛皮多格雷尔治疗的罕见但显著的不良反应.
研究的目的:
- 为了突出使用克洛皮多格雷尔和TTP之间的关联.
- 强调在用克洛皮多格雷尔治疗的患者中识别TTP的重要性.
- 强调需要及时诊断和管理皮格瑞尔诱导的TTP.
主要方法:
- 案例报告的呈现方式.
- 基于特征性症状的TTP的临床诊断.
- 通过在克洛皮多格雷尔停用后症状的消失来确认诊断.
主要成果:
- 一名患者在进行STEMI的PCI后服用克洛皮多格勒后出现了TTP.
- 症状包括血栓细胞减小,溶血性贫血,神经障碍和功能障碍.
- 通过 discontinuing clopidogrel 取得成功的管理,导致症状的解决.
结论:
- 克洛皮多格雷尔可以诱导TTP,需要临床警.
- 早期检测和停止使用克洛皮多格雷尔对于有利的患者结果至关重要.
- 提高医疗保健提供者对这种罕见并发症的认识至关重要.
相关概念视频
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Venous Thrombosis I: Introduction
294
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
294
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Disorders of Hemostasis
1.9K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K
Formation of the Platelet Plug
8.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K
Clot Retraction and Fibrinolysis
8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K

